A sweet mix to rescue Diabetes-too good to be true: Isomaltulose (IM)/Trehalose (TH) [IMTH]-based regenerative therapy for reversing diabetes: A pharmaceutical mixture encompassing Isomaltulose (IM) and Trehalose (TH) [IMHT]  increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene, 2/May/2018, 1.32 pm

Bariatric surgery protects against cardiac hypertrophy and fibrosis: Bariatric surgery, a gastrointestinal surgery for weight loss and  for uncontrolled diabetes, decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1, and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via upregulation of its target gene, 1/May/2019, 12.48 am
April 30, 2019
GDF8-based therapy for hyperglycemia: GDF8 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of  its target gene Lin28, 2/May/2019, 1.47 pm
May 2, 2019
Show all

Introduction: What they say

A study from the Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, 3715 McClintock Avenue, Los Angeles, California, USA; and Koch Institute at MIT, 500 Main Street, Cambridge, USA shows that “Fasting-Mimicking Diet Promotes Ngn3-Driven ß-Cell Regeneration to Reverse Diabetes.” This research paper was published, in the 23 February 2017 issue of the journal “Cell” [One of the best research journals in Biology with an I.F of 28 plus], by  Prof. and Director of Longevity institute Valter Longo, Cheng CW and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  A sweet mix to rescue Diabetes-too good to be true: Isomaltulose (IM)/Trehalose (TH) [IMTH]-based regenerative therapy for reversing diabetes: A pharmaceutical mixture encompassing Isomaltulose (IM) and Trehalose (TH) [IMTH]  increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene

 

[easy_payment currency=”USD”]


From significance of the study to Public health relevance:

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells that were lost in DM; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

It has recently been shown that fasting mimicking diet (FMD):(1) increases the expression of Sox17, Pdx-1 (Pancreatic And Duodenal Homeobox 1), & Ngn3 (Neurogenin-3) sequentially; (2) promotes regeneration of insulin-producing ß cells; (3) decreases PKA (Protein Kinase A) and mTOR activity; (4) increases reprogramming proteins Sox2 and Ngn3 expression; (5) increases insulin secretion; and (6) promotes glucose homeostasis, suggesting that FMD: (i) promotes reprogramming of pancreatic cells to restore insulin secretion in islets; and (ii) can reverse both T1D and T2D.


From research findings to Therapeutic opportunity:

Isomaltulose(IM)/Palatinose consists of  glucose and fructose, while Trehalose (TH) consists of two molecules of glucose.  This study suggests, for the first time, a disaccharide mix (Isomaltulose/Palatinose+Trehalose (TH))-based regenerative therapy for T1D and TIID.

Isomaltulose/Palatinose, isolated from honey and sugar cane extract, and Trehalose, isolated from seaweeds and mushrooms, have been shown to decrease blood sugar and promote weight loss. However, the mechanism of action these sugar molecules remain elusive.

A pharmaceutical mixture encompassing Isomaltulose (IM) and Trehalose (TH) [IMTH], by increasing the expression of its target genes, it may increase the expression of Sox17, Ngn3, Sox2, Pdx-1, NKX6.1, Pax6, INS etc. (Fig. 1). Thereby,  it may: (1) decrease the expression of mTOR;  (2) increase generation of insulin-producing ß cells; (3) increase insulin secretion; and (4) promote glucose homeostasis, suggesting that IMTH-based therapy–may replace the need for FMD (Fast mimicking diet) or function as an effective alternative to FMD–may find its use in clinic in attenuating and/or reversing both T1D and T2D, as it turns on most of the reprogramming/insulin-producing genes turned by the FMD (Fig.1).

Figure 1. Mechanistic insights into a therapeutic mix encompassing Isomaltulose (IM) and Trehalose (TH) [IMTH], by turning on the expression of Ngn3, NKX6.1, Pax6, and INS and others anti-diabetic genes, may promote reprogramming of pancreatic cells to restore insulin secretion in islets; and reverse both T1D and T2D.

Figure 2. A therapeutic mix encompassing Isomaltulose (IM) and Trehalose (TH) [IMTH] may in cancelling out diabetes.

Thus, a therapeutic mix encompassing Isomaltulose (IM) and Trehalose (TH) [IMHT] or their analogs, either alone or in combination with other compounds, may be used to treat and cure T1D and T2D (Fig.2).

Together, this study suggests, for the first time, that IMTH-based therapy may be used to treat and/or cure T1D and T2D; and may function as an effective alternative to FMD.

[easy_payment currency=”USD”]


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does IMTH increase the expression of Sox17, Sox2, Pdx-1, and Ngn3?

Amount: $750#

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L.,  A sweet mix to rescue Diabetes-too good to be true: Isomaltulose (IM) and Trehalose (TH) [IMTH]-based regenerative therapy for reversing diabetes: A pharmaceutical mixture encompassing Isomaltulose (IM) and Trehalose (TH) [IMTH]  increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene, 2/May/2018, 1.32 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, drop us a line at info@genomediscovery.org

Comments are closed.